| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |